Stay updated on Atacicept in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.

Latest updates to the Atacicept in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedAdded a Locations section with California as a location, and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPublications section wording now states that publications are automatically filled from PubMed. The revision label was updated to v3.3.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe funding-lapse warning was removed from the page, removing explicit guidance about information recency and operating status resources. This could affect how users gauge the currency of the displayed study details and where to find status updates.SummaryDifference0.4%

- Check45 days agoChange DetectedA new publication citation was added under Publications: 'A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy' (N Engl J Med, 2025, Online ahead of print).SummaryDifference0.1%

- Check52 days agoChange DetectedThe updates appear to be formatting adjustments and a refreshed update timestamp, with no changes to critical trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedAdds an operating-status notice, new dates, and a newer revision; removes older dates and a product-origin statement. The key impact is updating the page’s status and version information.SummaryDifference6%

Stay in the know with updates to Atacicept in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.